SomaLogic Obtains $9,999,997 New Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2945 Wilderness Place Boulder, CO 80301
  • Company Description
    SomaLogic, Inc. is developing novel proteomics systems and applications based on its proprietary aptamer technology. Aptamers are single-stranded DNA and RNA molecules that, like antibodies, can bind to target molecules with high affinity and specificity.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor